GlassScriptPhysician profile
Scott R Partridge
NPI 1043285885
$2,019.61
in general payments reported to CMS, 2019-2025
27 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $94.50 · 2021: $377 · 2022: $517 · 2023: $268 · 2024: $345 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $368.15 | 2019-2023 | |
| Myovant Sciences INC. | $281.12 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $216.17 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $136.44 | 2023-2025 | Myfembree |
| Biogen, INC. | $135.88 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $101.55 | 2023-2025 | Veozah |
| Daiichi Sankyo INC. | $101.16 | 2021-2024 | Injectafer |
| Coopersurgical, INC. | $85.46 | 2019-2025 | Paragard T 380a |
| Agile Therapeutics, INC. | $60.06 | 2021 | |
| Pfizer INC. | $58.24 | 2024 | |
| Optumhealth Care Solutions, LLC | $47.62 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Amag Pharmaceuticals, INC. | $44.56 | 2019 | |
| Hologic Sales and Service, LLC | $39.07 | 2020-2021 | |
| Therapeuticsmd, INC. | $39.05 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $37.52 | 2022-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $34.53 | 2019-2023 | Harmonic |
| Lupin INC. | $27.94 | 2019 | |
| Shield Therapeutics INC | $26.10 | 2023 | Accrufer |
| Medtronic, INC. | $26.08 | 2022 | |
| Allergan, INC. | $23.31 | 2019 | |
| Aspira Women'S Health INC | $23.14 | 2024 | Ova1 |
| Roche Diagnostics Corporation | $21.85 | 2019 | |
| Gynesonics, INC. | $19.83 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pacira Pharmaceuticals Incorporated | $18.74 | 2022 | |
| Evofem Biosciences, INC. | $16.94 | 2021 | |
| Covidien LP | $15.33 | 2019 | |
| Minerva Surgical, INC | $13.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Partridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.